<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="28398">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01873716</url>
  </required_header>
  <id_info>
    <org_study_id>2012P000895</org_study_id>
    <nct_id>NCT01873716</nct_id>
  </id_info>
  <brief_title>Indocyanine Green Fluorescence Uptake in Human Carotid Artery Plaque</brief_title>
  <acronym>BRIGHT-CEA</acronym>
  <official_title>Indocyanine Green Fluorescence Uptake in Human Carotid Artery Plaque -- A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This will be a pilot study of 9 patients undergoing standard-of-care clinically indicated
      carotid endarterectomy. The nine patients will receive an injection of Indocyanine green
      (ICG) at a dose of 0.25 mg/kg (maximum 25 mg) as an intravenous bolus.

      Immediately following endarterectomy, the resected specimen will be immersed in normal
      saline. Ex vivo fluorescence reflectance imaging (FRI) and immunohistochemistry will be
      performed.

      The investigators hypothesize that compared to controls, ICG-injected patients will
      demonstrate increased ex vivo and microscopic ICG fluorescence signal within areas of
      plaque.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">May 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Tissue uptake of indocyanine green in carotid plaque</measure>
    <time_frame>within 3 months after carotid endarterectomy</time_frame>
    <safety_issue>No</safety_issue>
    <description>Characterize tissue distribution of indocyanine green in human carotid artery specimens after carotid endarterectomy using fluorescence microcopy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Relationship of indocyanine green uptake to carotid plaque histology</measure>
    <time_frame>within 3 months after carotid endarterectomy</time_frame>
    <safety_issue>No</safety_issue>
    <description>Analysis of tissue distribution of indocyanine green in human carotid artery specimens after carotid endarterectomy using histopathology</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">9</enrollment>
  <condition>Atherosclerosis</condition>
  <condition>Atherosclerotic Plaque</condition>
  <condition>Carotid Stenosis</condition>
  <arm_group>
    <arm_group_label>Injection of Indocyanine Green</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Injection of Indocyanine Green prior to carotid endarterectomy surgery. Collection of specimen during surgery with subsequent carotid tissue analysis.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No injection</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No injection prior to carotid endarterectomy surgery. Collection of specimen during surgery with subsequent carotid tissue analysis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Indocyanine green</intervention_name>
    <description>Indocyanine green (ICG) for injection, 0.25mg/kg intravenously. A maximum of 25mg is given, approximately 30-60 minutes before carotid endarterectomy</description>
    <arm_group_label>Injection of Indocyanine Green</arm_group_label>
    <other_name>FDA Application No. (ANDA) 040811</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Consecutive patients scheduled for elective carotid endarterectomy at Massachusetts
             General Hospital

          -  Age &gt; 18 years of age.

          -  Signed informed consent.

        Exclusion criteria:

          -  Hemodynamic instability

          -  Any history of iodide allergy

          -  Any history of renal failure (estimated Glomerular Filtration Rate (eGFR) &lt;50
             ml/min/1.73 m2)

          -  Any history of liver failure

          -  Any history of bleeding diathesis

          -  Any history of cerebral vascular accident in the preceding 3 months

          -  Pregnant or lactating females.

          -  Hx of seafood allergy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Farouc A Jaffer, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Farouc A Jaffer, MD PhD</last_name>
    <phone>617-724-9353</phone>
    <email>fjaffer@mgh.harvard.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Heather A Marino-Mitchell, MLA</last_name>
    <phone>617-643-9325</phone>
    <email>hamarino@partners.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Farouc A Jaffer, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Vinegoni C, Botnaru I, Aikawa E, Calfon MA, Iwamoto Y, Folco EJ, Ntziachristos V, Weissleder R, Libby P, Jaffer FA. Indocyanine green enables near-infrared fluorescence imaging of lipid-rich, inflamed atherosclerotic plaques. Sci Transl Med. 2011 May 25;3(84):84ra45. doi: 10.1126/scitranslmed.3001577.</citation>
    <PMID>21613624</PMID>
  </reference>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>June 6, 2013</lastchanged_date>
  <firstreceived_date>May 23, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Farouc Amin Jaffer</investigator_full_name>
    <investigator_title>Associate Professor of Medicine, Harvard Medical School</investigator_title>
  </responsible_party>
  <keyword>Atherosclerosis</keyword>
  <keyword>Molecular Imaging</keyword>
  <keyword>Vascular Biology</keyword>
  <keyword>Inflammation</keyword>
  <keyword>Fluorescence</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Carotid Stenosis</mesh_term>
    <mesh_term>Plaque, Atherosclerotic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
